Chloralhydrate in children undergoing echocardiography

Area of Science:

• Pediatric Cardiology
• Pharmacology
• Medical Imaging

Background:

• Transthoracic echocardiography (TTE) is essential for diagnosing congenital heart disease in children.
• Optimal TTE imaging often necessitates sedation due to patient movement.
• Chloral hydrate (CH) is commonly used for pediatric sedation.

Purpose of the Study:

• To evaluate the safety and efficacy of chloral hydrate (CH) for sedation during TTE in pediatric patients.
• To assess the impact of CH on vital signs and identify potential adverse events.

Main Methods:

• A prospective study involving 360 pediatric patients (2 weeks to 8 years) undergoing TTE.
• Chloral hydrate administered orally or rectally at a median dose of 75 mg/kg.
• Continuous monitoring of respiratory rate, heart rate, blood pressure, and oxygen saturation before, during, and after sedation.

Main Results:

• Successful sedation was achieved in 95% (342/360) of patients.
• No clinically significant changes in heart rate, blood pressure, or respiratory rate were observed.
• No significant differences in vital signs were noted before and after CH administration.

Conclusions:

• Chloral hydrate is a safe and effective sedative for pediatric TTE, despite potential issues with taste and gastric irritation.
• Minimal side effects and high efficacy support the continued use of CH for TTE procedures in children.
• CH facilitates successful TTE by providing adequate sedation with a favorable safety profile.